Skip to main content
Year archive

Vaxfab Enterprises Limited — 2023 filings

All 81 regulatory filings released by Vaxfab Enterprises Limited (542803) in 2023, sourced directly from the official regulator.

81 Filings
2023 Period
2023 filings (81)
Filing Released Lang
Closure of Trading window
Regulatory Filings
2023-12-29 English
Newspaper Advertisement of extract of Unaudited Financial Results for the Quarter and Half Year ended on 30th September, 2023
Regulatory Filings
2023-11-10 English
Unaudited Financial Results for the Quarter ended on 30th September, 2023
Regulatory Filings
2023-11-08 English
Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company, in their meeting ....
Regulatory Filings
2023-11-08 English
Vaxfab Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 ,inter alia, to consider and approve Pursuant to Regulation 29(1) ....
Regulatory Filings
2023-10-30 English
Statement on deviation or variation for proceeds of Right issue
Regulatory Filings
2023-10-21 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shani Bhati
Regulatory Filings
2023-10-13 English
Regulation 74(5) of SEBI (DP) Regulation, 2018
Regulatory Filings
2023-10-10 English
Closure of Trading Window as per attachment
Regulatory Filings
2023-09-30 English
Scrutinizer Report for Annual General Meeting of 2022-23.
Regulatory Filings
2023-09-26 English
Outcome of Annual General Meeting held today i.e. 23rd September, 2023 in terms of the Regulation 30 of the SEBI (LODR) Regulation, 2015
Regulatory Filings
2023-09-23 English
Submission of Newspaper Advertisement for Notice of AGM, Book Closure & E-Voting.
Regulatory Filings
2023-09-02 English
Pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith the Annual Report of the 40th Annual General Meeting ....
Regulatory Filings
2023-09-01 English
Intimation of Book Closure pursuant to Regulation 42 of the SEBI (LODR) Regulation, 2015
Regulatory Filings
2023-09-01 English
Outcome of Board Meeting held today i.e. 1st September, 2023
Regulatory Filings
2023-09-01 English
Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors in their meeting held today ....
Regulatory Filings
2023-09-01 English
With reference to the application made by company dated 18th August ,2022, regarding the Reclassification of certain shareholders from ''Promoter and Promoter Group'' category to ''Public'' ....
Regulatory Filings
2023-08-19 English
With reference to application made by company dated 18th August, 2022, regarding the reclassification of certain shareholders from '' Promoter and Promoter Group'' category to ''Public'' ....
Regulatory Filings
2023-08-19 English
Appointment of Company Secretary and Compliance Officer.
Regulatory Filings
2023-08-18 English
Pursuant to second proviso to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the company, ....
Regulatory Filings
2023-08-18 English
Newspaper Advertisement of extract of Unaudited Financial Results for the Quarter ended on 30th June, 2023.
Regulatory Filings
2023-08-08 English
Press Release
Regulatory Filings
2023-08-05 English
Submission of Standalone and Consolidated Financial Result for the Quarter ended on 30th June, 2023 along with Limited Review Report.
Regulatory Filings
2023-08-05 English
Pursuant to second proviso to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company, ....
Regulatory Filings
2023-08-05 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ashok Korat
Regulatory Filings
2023-07-19 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shani Bhati
Regulatory Filings
2023-07-19 English
Vaxfab Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2023 ,inter alia, to consider and approve We hereby inform you that ....
Regulatory Filings
2023-07-18 English
Kindly find the attached compliance certificate under Regulation 74(5) of SEBI (Depository and Participants) Regulations, 2018.
Regulatory Filings
2023-07-17 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ashok Korat
Regulatory Filings
2023-07-17 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shani Bhati
Regulatory Filings
2023-07-17 English
Pursuant to Regulation 31A(8)(C) of SEBI (Listing Obligation and Disclosure Requirement ) Regulation 2015, We here by inform you that the company had submitted application for re-classification ....
Regulatory Filings
2023-07-11 English
Intimation of Closure of Trading Window
Regulatory Filings
2023-06-30 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ashok Korat
Regulatory Filings
2023-05-25 English
Took note of Resignation of Ms. Komal Hirenkumar Jain as Company Secretary & Compliance Officer of the Company w.e.f 16th May, 2023. The Board has accepted her resignation and has relieved ....
Regulatory Filings
2023-05-17 English
Took note of Resignation of Ms. Komal Hirenkumar Jain as Company Secretary & Compliance Officer of the Company w.e.f 16th May, 2023. The Board has accepted her resignation and has relieved ....
Regulatory Filings
2023-05-17 English
Declaration of Unmodified Opinion of Audit Report by Statutory Auditor for the Year Ended - March 2023
Regulatory Filings
2023-05-13 English
1) Resignation of Yash Chauhan (DIN: 09754778) as Director of the Company w.e.f 11th May, 2023. The Board has accepted his resignation and has relieved him from the responsibilities w.e.f. ....
Regulatory Filings
2023-05-11 English
Pursuant to Regulation 47, 52 and Regulation 30 read with Schedule III Part A, Para A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, ....
Regulatory Filings
2023-05-04 English
Pursuant to Regulation 32 of the SEBI Listing Regulations and SEBI Circular No. CIR/CFD/CMD1/162/2019 dated December 24, 2019, please note that there are no deviation(s) or variation(s) ....
Regulatory Filings
2023-05-03 English
we hereby inform you that the Board of Directors of the Company, in their meeting held today, i.e. on 2nd May, 2023, at the Registered Office of the Company, which commenced at 6:00 p.m. ....
Regulatory Filings
2023-05-02 English
Pursuant to Regulation 40(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Please find attached herewith the Certificate ....
Regulatory Filings
2023-04-25 English
Vaxfab Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/05/2023 ,inter alia, to consider and approve 1. To consider and approve ....
Regulatory Filings
2023-04-22 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings
2023-04-19 English
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 by Skyline Financial Service Private Limited for the quarter ended March 31, 2023
Regulatory Filings
2023-04-07 English
Pursuant to regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations,2015, please find enclosed herewith a copy of Certificate duly signed by Registrar and ....
Regulatory Filings
2023-04-07 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ashok Korat
Regulatory Filings
2023-03-31 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shani Bhati
Regulatory Filings
2023-03-31 English
Pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and amendments made thereunder and Company''''s Code of Conduct for Prevention ....
Regulatory Filings
2023-03-27 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings
2023-03-06 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Qmin Industries Pvt Ltd
Regulatory Filings
2023-03-03 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ashok Korat
Regulatory Filings
2023-03-03 English
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ashok Korat
Regulatory Filings
2023-03-03 English
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Qmin Industries Pvt Ltd
Regulatory Filings
2023-03-03 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shani Bhati
Regulatory Filings
2023-03-02 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shani Bhati
Regulatory Filings
2023-03-02 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vax Enterprise Pvt Ltd
Regulatory Filings
2023-03-02 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ashok Korat
Regulatory Filings
2023-03-01 English
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Qmin Pharma Pvt Ltd
Regulatory Filings
2023-02-28 English
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vax Enterprise Pvt Ltd
Regulatory Filings
2023-02-28 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vax Enterprise Pvt Ltd
Regulatory Filings
2023-02-28 English
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jaimin Kailash Gupta
Regulatory Filings
2023-02-28 English
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Hitesh Loonia & Vishala Loonia
Regulatory Filings
2023-02-28 English
Pursuant to the provision of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we wish to inform you that, today i.e. 20th February 2023, the ....
Regulatory Filings
2023-02-21 English
With reference to application made by the Company dated 9th November, 2022, regarding the proposed Rights Issue of Fully Paid-up Equity shares by the Company. We would like to inform you ....
Regulatory Filings
2023-02-21 English
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Regulation 92 of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, ....
Regulatory Filings
2023-02-20 English
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 ("the Regulations"), we hereby inform you that the Rights Issue Committee of the Board ....
Regulatory Filings
2023-02-16 English
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ashokbhai Madhubhai Korat
Regulatory Filings
2023-02-08 English
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shani Bhati
Regulatory Filings
2023-02-07 English
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vax Enterprise Pvt Ltd
Regulatory Filings
2023-02-07 English
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Regulation 84 of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, ....
Regulatory Filings
2023-01-23 English
With reference to the captioned Rights Issue, we would like to inform you that as per the resolution passed by the Board of Directors of the Company dated 21st January, 2022 the date of ....
Regulatory Filings
2023-01-21 English
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Regulation 84 of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, ....
Regulatory Filings
2023-01-16 English
Newspaper Advertisement of extract of Unaudited Financial Results for the Quarter and Nine Months ended on 31st December, 2022.
Regulatory Filings
2023-01-13 English
Pursuant to second proviso to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the Press Release for the Unaudited Financial Result ....
Regulatory Filings
2023-01-11 English
In reference to captioned subject and pursuant to Regulation 33(3) (d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are hereby submitting the Unaudited ....
Regulatory Filings
2023-01-11 English
Pursuant to second proviso to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company, ....
Regulatory Filings
2023-01-11 English
Pursuant to second proviso to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company, ....
Regulatory Filings
2023-01-11 English
With reference to the captioned subject, we hereby submit the confirmation Certificate received from M/s. Skyline Financial Services Private Limited, Registrar and Share Transfer Agent ....
Regulatory Filings
2023-01-09 English
We refer to your letter with regard to the significant movement in the price of the Company''s script on Stock exchange. In this connection, we wish to inform you that we have no price ....
Regulatory Filings
2023-01-09 English
Pursuant to second proviso to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors in their meeting ....
Regulatory Filings
2023-01-07 English
Vaxfab Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/01/2023 ,inter alia, to consider and approve This is to inform you that ....
Regulatory Filings
2023-01-04 English